Vanguard Group Inc. increased its stake in Abbott Laboratories (NYSE:ABT) by 0.2% in the third quarter, now owning 9.96% of the company’s shares worth approximately $23.19 billion. Abbott Laboratories reported meeting EPS estimates for the quarter but slightly missed revenue expectations, yet raised its quarterly dividend to $0.63. Additionally, a company director purchased 10,000 shares, indicating insider confidence.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Abbott Laboratories $ABT Shares Purchased by Vanguard Group Inc.
Vanguard Group Inc. increased its stake in Abbott Laboratories (NYSE:ABT) by 0.2% in the third quarter, now owning 9.96% of the company’s shares worth approximately $23.19 billion. Abbott Laboratories reported meeting EPS estimates for the quarter but slightly missed revenue expectations, yet raised its quarterly dividend to $0.63. Additionally, a company director purchased 10,000 shares, indicating insider confidence.